JV

Julie Vimal Jaswa

Active Director Director DIN 01770733
DIN 01770733 First appointment Mar 2019 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2019
Shareholding value •••• Premium profile

About Julie Vimal Jaswa

Data last updated:

Julie Vimal Jaswa is a Director at Usan Pharmaceuticals Private Limited (since 2019). The company operates in Pharma. Usan Pharmaceuticals Private Limited reported revenue of ₹29.79 Cr (FY 2025).

DIN 01770733
Primary Designation Director
Industry Pharma
First Appointment 15 Mar 2019
Oldest Company Age 52 yrs
Largest company Usan Pharmaceuticals Private Limited · ₹29.79 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Usan Pharmaceuticals Private Limited U24239MH1974PTC017730
Director15 Mar 20191974₹29.79 Cr (FY 2025)Active

Board colleagues of Julie Vimal Jaswa

NameDINCompanyDesignation
Vimal Jaswa00427839Usan Pharmaceuticals Private LimitedManaging Director

Directorship timeline

Open interactive timeline →
Usan Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Julie Vimal Jaswa

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Julie Vimal Jaswa

Julie Vimal Jaswa currently holds 1 directorship: Usan Pharmaceuticals Private Limited (Director, since 15 Mar 2019, revenue ₹29.79 Cr (FY 2025)).

Julie Vimal Jaswa was first appointed on 15 Mar 2019 as Director at Usan Pharmaceuticals Private Limited.

The current boards of Julie Vimal Jaswa's companies include Vimal Jaswa (Usan Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available